While efforts to repeal the Affordable Care Act were narrowly defeated, grave problems in health care persist. Twenty-eight million remain uninsured, a number that is likely to increase. Millions more who have coverage cannot afford care because of high cost-sharing requirements. Meanwhile, the corporate takeover of medical care in the United States is at a gallop. This article provides a brief précis of recent data on U.S. health policy.
BarnettJCBerchickBR. Health insurance coverage in the United States: 2016. Washington, D.C., U.S. Census Bureau: September 2017; Collins SR, Gunja MZ, Doty MM, Beutel S. How the Affordable Care Act has improved Americans’ ability to buy health insurance on their own. Commonw Fund. Published February 1, 2017.
ShermanBWGibsonTBLynchWDAddyC.Health care use and spending patterns vary by wage level in employer-sponsored plans.Health Aff. 2017;
36:250–257. https://doi.org/10.1377/hlthaff.2016.1147
CohenRAMartinezMEZammittiEP. Health insurance coverage: early release of estimates from the National Health Interview Survey, January–March, 2017. National Center for Health Statistics. https://www.cdc.gov/nchs/data/nhis/earlyrelease/insur201708.pdf. Published August 2017.
NovakNLGeronimusATMartinez-CardosoAM.Change in birth outcomes among infants born to Latina mothers after a major immigration raid. Int J Epidemiol. 2017;
46:839–849.
KhullarDBlumenthalDMOlenskiARJenaAB.U.S. immigration policy and American medical research: the scientific contributions of foreign medical graduates.Ann Intern Med. 2017;
167:584–585.
15.
AllenHSwansonAWangJGrossT.Early Medicaid expansion associated with reduced payday borrowing in California.Health Affairs. 2017;
36:1769–1776.
16.
PikettyTSaezEZucmanG. Distributional national accounts: methods and estimates for the United States. NBER Working Paper 22945. http://www.nber.org/papers/w22945.
17.
PrasadVMailankodyS.Research and development spending to bring a single cancer drug to market and revenues after approval.JAMA Intern Med. 2017;
177:1569–1575.
18.
LexchinJ.The relation between promotional spending on drugs and their therapeutic gain: a cohort analysis.CMAJ Open. 2017;
5:E724–E728.
19.
WoloshinSSchwartzLWhiteBMooreTJ.The fate of FDA post approval studies.N Engl J Med. 2017;
377:1114–1117.
Ranked within industries. Fortune 500. June 15, 2017:f33–40. http://fortune.com/fortune500; Commerce Department Service Annual Surveys, first quarter of 2016.
22.
TringaleKRMarshallDMackeyTKConnorMMurphyJDHattangadi-GluthJA.Types and distribution of payments from industry to physicians in 2015.JAMA. 2017;
317:1774–1784.
23.
DarkCXuYHoV.Freestanding emergency departments preferentially locate in areas with higher household income.Health Affairs. 2017;
36:1712–1719.
24.
HorwitzJRHsuanCNicholsA. The role of hospital and market characteristics in invasive cardiac service diffusion. NBER Working Paper No. 23530. http://www.nber.org/papers/w23530. Published June 2017.
25.
FultonDB.Health care market concentration trends in the United States: evidence and policy responses.Health Affairs. 2017;
36:1530–1538; and Roberts ET, Chernew M, McWilliam MW. Market share matters: evidence of insurer and provider bargaining over prices. Health Affairs. 2017;36:141–148.
26.
SchoenCCollinsSR.The big five health insurers’ membership and revenue trends: implications for public policy.Health Affairs. 2017;
36:2185–2194.
GuptaAAllenLABhattDLet al. Association of the Hospital Readmissions Reduction Program implementation with readmission and mortality outcomes in heart failure. JAMA Cardiol. Published November12, 2017.
32.
StenslandJGaumerZRMillerME.Contrary to popular belief, Medicaid hospital admissions are often profitable because of additional Medicare payments.Health Affairs. 2016;
35:2282–2288.
33.
BarnettMLGrabowskiDCMehrotraA.Home-to-home time: measuring what matters to patients and payers.N Engl J Med. 2017;
377:4–6.
34.
CurtoVEinavLFinkelsteinALevinJDBhattacharyaJ. Healthcare spending and utilization in public and private Medicare. NBER Working paper No. 23090. January, 2017.
35.
ParkSBasuACoeNKhalilF. Service-level selection: strategic risk selection in Medicare Advantage in response to risk adjustment. NBER Working Paper 24038, November, 2017.
36.
RyanAMKrinskySMaurerKADimickJB.Changes in hospital quality associated with hospital value-based purchasing.N Engl J Med. 2017;
376:2358–2366; Papanicolas I, Figueroa JF, Orav EJ, Jha AK. Patient hospital experience improved modestly, but no evidence Medicare incentives promoted meaningful gains. Health Affairs. 2017;36:133–140.
37.
ChenLMEpsteinAMOravJ.Association of practice-level social and medical risk with performance on the Medicare physician value-based payment modifier program.JAMA. 2017;
318:453–461. Another study reached similar conclusions, prompting its authors to comment: “We’ve gone headlong into pay-for-performance despite study after study showing that it doesn’t improve quality or lower overall spending.” Source: Roberts ET, Zaslavsky AM, McWilliams JM. The value-based payment modifier: program outcomes and implications for disparities. Ann Intern Med. Online first. November 28, 2017. doi:10.7326/M17-1740; Commins J. Medicare pay-for-performance didn’t deliver. Health Leaders Media. http://www.healthleadersmedia.com/quality/medicare-pay-performance-didnt-deliver. Published November 30, 2017.
38.
Department of Health and Human Services, Office of Inspector General. Medicare shared savings program accountable care organizations have shown potential for reducing spending and improving quality. August 2017. OEI-02-15-00450. https://oig.hhs.gov/oei/reports/oei-02-15-00450.pdf; Castellucci M. CMS loses money as Medicare ACOs remain risk-averse. Modern Healthcare. Published October 31, 2017.
39.
MansourMFaviniN ,CaromeMA ,WolfeS ,WoolhandlerS ,HimmelsteinDU.Accountable care organizations’ payments to physicians: patients should have the right to know.Am J Public Health. 2017;
107:1251–1252.
40.
StephensonALSykesJStanojevicSet al.
Survival comparison of patients with cystic fibrosis in Canada and the United States: a population-based cohort study.Ann Intern Med. 2017;
166:537–546.
41.
FrenchEBMcCauleyJAragonMBakxPet al.
End-of-life medical spending in last twelve months of life is lower than previously reported.Health Affairs. 2017;
36:1211–1217; Griffin S, Cubanski J, Neuman T, et al. Medicare and end-of-life care. JAMA. 2016;316:1754.
OsbornRDotyMMMouldsDSarnakDOShahA.Older Americans were sicker and faced more financial barriers to health care than counterparts in other countries. Health Affairs. 2017;36:2123-2132.
44.
WangMDKhannaRNajafiN.Characterizing the source of text in electronic health record progress notes.JAMA. 2017;
177:1212–1213.
